Bin Xu
Associate Attending Pathologist · New York Presbyterian Hospital
Credentials: · · · ·
History
- 2009–2013
- 2005–2009
Research
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
New England Journal of Medicine · 2022 · 2,268 citations
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
Journal of Clinical Investigation · 2016 · 1,006 citations
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer
New England Journal of Medicine · 2022 · 991 citations
- RG
125 papers
- NK
68 papers
47 papers
- SD
44 papers
- MT
29 papers
23 papers
- BA
19 papers · 15 as a resident
- SP
19 papers
Grants
- 2026–2028
Bottom-Up Mass Spectrometry Imaging of Tissue Proteins
National Institute of Mental Health · R21
PI · $406.5K · New Jersey Institute of Technology
- 2016–2021
Integrative Methods for the Identification of Causal Variants in Mental Disorder
National Institute of Mental Health · R01
PI · $1.2M · Columbia University Health Sciences